What is the significance of periportal adenopathy in a patient with hepatic cirrhosis?

1994 ◽  
Vol 163 (3) ◽  
pp. 742-742 ◽  
Author(s):  
H I Goldberg
Keyword(s):  
Hepatic Cirrhosis

Analysis of haemodynamic changes related to hepatic cirrhosis by an ultrasound contrast agent

2001 ◽  
Vol 120 (5) ◽  
pp. A2-A2
Author(s):  
G FELICIANGELI ◽  
G ARGALIA ◽  
L BOLOGNINI ◽  
T ABBATTISTA ◽  
M URBANI ◽  
...  
Keyword(s):  
Contrast Agent ◽  
Hepatic Cirrhosis ◽  
Ultrasound Contrast Agent ◽  
Ultrasound Contrast ◽  
Haemodynamic Changes

Distinctive Nail Changes in Advanced Hepatic Cirrhosis

1955 ◽  
Vol 29 (2) ◽  
pp. 258-261 ◽  
Author(s):  
Dennis A.J. Morey ◽  
James O. Burke
Keyword(s):  
Hepatic Cirrhosis ◽  
Nail Changes

Morphine tolerance in hepatic cirrhosis

1961 ◽  
Vol 40 (3) ◽  
pp. 389-396 ◽  
Author(s):  
John Laidlaw ◽  
A.E. Read ◽  
Sheila Sherlock
Keyword(s):  
Hepatic Cirrhosis ◽  
Morphine Tolerance

The intestinal microbiota changes paradigms in hepatic cirrhosis

Infectio ro ◽  
2017 ◽  
Vol 3 (51) ◽  
Author(s):  
Gabriela-Loredana Popa ◽  
Silvana-Adelina Gheorghe ◽  
Mădălina Preda
Keyword(s):  
Intestinal Microbiota ◽  
Hepatic Cirrhosis

EFFICACY OF LAMIVUDINE IN PATIENTS WITH HBV- RELATED HEPATIC CIRRHOSIS

2012 ◽  
pp. 107-113
Author(s):  
Van Huy Tran ◽  
Hoai Phong Nguyen
Keyword(s):  
Viral Replication ◽  
Antiviral Therapy ◽  
Hepatic Cirrhosis ◽  
Hbeag Seroconversion ◽  
Hbv Dna ◽  
Hbeag Loss ◽  
Complications Of Cirrhosis

Background: The recent studies concerning antiviral therapy in HBV-related cirrhosis showed the promising results. This study is aimed at assessing efficacy of lamivudine in patients with HBV-related cirrhosis. Patients and methods: 41 patients with HBsAg positive-cirrhosis and evidence of viral replication were enrolled in the study. Lamivudine is given 100 mg per day and the follow-up is 12 months. Results: The rates of HBV DNA undetectable was 58.53%, 68.29% and 87.80% after 36.6 and 12 months, respectively. The rate of HBeAg loss and HBeAg seroconversion are 57.14% and 35.71%. Child-Pugh scores decreased significantly after 6 and 12 months. The complications of cirrhosis were infrequent. Conclusion: Lamivudine appeared effective and safe in HBV-related hepatic cirrhosis.

Icaritin delays CCl4-induced hepatic cirrhosis in rats by protecting hepatocytes from oxidative injury

2011 ◽  
Vol 31 (6) ◽  
pp. 625-629 ◽  
Author(s):  
Hai-hua QIAN ◽  
Peng LIU ◽  
Jing LI ◽  
Lei CHEN ◽  
Lu CAO ◽  
...  
Keyword(s):  
Hepatic Cirrhosis ◽  
Oxidative Injury

scholarly journals Determinants of Erythrocyte Size in Chronic Liver Disease

Blood ◽  
1969 ◽  
Vol 34 (6) ◽  
pp. 739-746 ◽  
Author(s):  
THOMAS M. KILBRIDGE ◽  
PAUL HELLER
Keyword(s):  
Bone Marrow ◽  
Liver Disease ◽  
Chronic Liver Disease ◽  
Peripheral Blood ◽  
Hepatic Cirrhosis ◽  
Alcoholic Cirrhosis ◽  
Clinical Findings ◽  
Red Cells ◽  
Red Cell ◽  
Cell Volumes

Abstract Serial determinations of red cell volumes were made with an electronic sizing device in 30 patients with hepatic cirrhosis. Variations in red cell volumes were correlated with other hematologic and clinical findings. The results of these studies suggest that volume macrocytosis in patients with alcoholic cirrhosis is either due to megaloblastosis of the bone marrow or to an accelerated influx of young red cells into the peripheral blood.

90 Bcs1L A232G mutant mice: A new model of complex III deficiency and hepatic cirrhosis

Mitochondrion ◽  
2010 ◽  
Vol 10 (2) ◽  
pp. 225
Author(s):  
Per Levéen ◽  
Heike Kotarsky ◽  
Eva Hanson ◽  
Eskil Elmér ◽  
Vineta Fellman
Keyword(s):  
Hepatic Cirrhosis ◽  
Mutant Mice ◽  
Complex Iii ◽  
New Model
Sign in / Sign up

Export Citation Format

Share Document